What’s New at GRAPPA

The GRAPPA app has launched!

The GRAPPA app, available in Apple and Android formats, is free to download from the Apple store and the Google Play Store.  Designed to be used by physicians, this app includes calculators for outcome measures including treat to target with the MDA criteria, the PASI and body surface area.  It also has the psoriasis epidemiology screening tool (PEST) questionnaire to screen for PsA in patients with psoriasis and the PsA impact of disease (PsAID) calculator to measure both PsAID 9 and PsAID 12.  Until mid-2018 the app is only available in English, but in the following months it will also launch in French, German, Italian, Spanish, Portuguese (for both Portugal and Brazil), Traditional Chinese, Simplified Chinese, Russian, Arabic, Japanese and Hebrew. Please check back for updates on these additional language versions.

We are very grateful for grant support from AbbVie, Eli Lilly, Novartis and Pfizer which allowed GRAPPA to complete this work.

The app is free to download to all, both GRAPPA members and non-members. Here are the links:

                                    
                                                                           Google Play and the Google Play logo are trademarks of Google LLC.

GRAPPA Mission

GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) is organized exclusively for non-profit, educational, and scientific purposes, specifically to facilitate sharing of information related to psoriasis and psoriatic arthritis, networking among different medical disciplines that see psoriasis and psoriatic arthritis patients, and to enhance research, diagnosis and treatment of psoriasis and psoriatic arthritis.

Pilot Research Grant Proposals Are In!

GRAPPA received 20 applications for its 2018 Pilot Research Grants from trainees and junior faculty by the deadline of May 25. The twenty grant proposals came from 14 countries and 19 universities and research institutions. The applications focused on a wide variety of psoriasis and psoriatic arthritis-related projects; laboratory-based, clinical and epidemiological. GRAPPA’s senior evaluators will score the proposals over the next few weeks and let the applicants know the outcome by the end of June. The 2018 GRAPPA Pilot Research Grant awardees will formally be announced at the GRAPPA Annual Meeting, July 12-14 in Toronto. GRAPPA will provide support for up to three projects at $25,000 each.